Ebos Group (ASX:EBO) Other Net Income (Loss) : A$0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Ebos Group Other Net Income (Loss)?

Ebos Group's Other Net Income (Loss) for the six months ended in Dec. 2023 was A$-0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 was A$0 Mil.

Ebos Group's quarterly Other Net Income (Loss) increased from Dec. 2022 (A$0 Mil) to Jun. 2023 (A$0 Mil) but then declined from Jun. 2023 (A$0 Mil) to Dec. 2023 (A$-0 Mil).

Ebos Group's annual Other Net Income (Loss) declined from Jun. 2021 (A$-0 Mil) to Jun. 2022 (A$-0 Mil) but then increased from Jun. 2022 (A$-0 Mil) to Jun. 2023 (A$0 Mil).

Ebos Group Other Net Income (Loss) Historical Data

The historical data trend for Ebos Group's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ebos Group Other Net Income (Loss) Chart

Ebos Group Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Net Income (Loss)

Get a 7-Day Free Trial

Ebos Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Ebos Group Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0 Mil.

Ebos Group Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Ebos Group's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Ebos Group (ASX:EBO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ebos Group Ltd (ASX:EBO) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

EBO:New Zealand EJG:Germany

Address

108 Wrights Road, P.O. Box 411, Christchurch, STL, NZL, 8024

Website

https://www.ebosgroup.com

Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.

Ebos Group (ASX:EBO) Headlines

No Headlines